These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9760134)

  • 21. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen.
    Hauber W; Münkle M
    Eur J Pharmacol; 1997 Apr; 323(2-3):127-31. PubMed ID: 9128830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors.
    Heese K; Fiebich BL; Bauer J; Otten U
    Neurosci Lett; 1997 Aug; 231(2):83-6. PubMed ID: 9291146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP; Richardson PJ
    Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
    Prentice DJ; Hourani SM
    Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.
    Kurokawa M; Koga K; Kase H; Nakamura J; Kuwana Y
    J Neurochem; 1996 May; 66(5):1882-8. PubMed ID: 8780014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relaxation of the ovine isolated iris sphincter by adenosine receptor agonists: lack of effect of adenosine A1 and A2 receptor antagonists.
    Hourani SM; Smith NC; Nettell JJ; Hall JM
    Eur J Pharmacol; 1997 Sep; 334(1):95-8. PubMed ID: 9346333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubilisation and immunoprecipitation of rat striatal adenosine A(2A) receptors.
    Harvey V; Jones J; Misra A; Knight AR; Quirk K
    Eur J Pharmacol; 2001 Nov; 431(2):171-7. PubMed ID: 11728423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease.
    Ikeda K; Kurokawa M; Aoyama S; Kuwana Y
    J Neurochem; 2002 Jan; 80(2):262-70. PubMed ID: 11902116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells.
    Salim H; Ferré S; Dalal A; Peterfreund RA; Fuxe K; Vincent JD; Lledo PM
    J Neurochem; 2000 Jan; 74(1):432-9. PubMed ID: 10617149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets.
    Uchida S; Soshiroda K; Okita E; Kawai-Uchida M; Mori A; Jenner P; Kanda T
    Eur J Pharmacol; 2015 Nov; 766():25-30. PubMed ID: 26415982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.
    Nash JE; Brotchie JM
    J Neurosci; 2000 Oct; 20(20):7782-9. PubMed ID: 11027242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosinergic and dopaminergic interaction in nigrostriatum in FeCl3-induced model of parkinsonism in rats.
    Mathur R; Gupta YK
    Methods Find Exp Clin Pharmacol; 1999; 21(6):435-9. PubMed ID: 10445237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M; Antoniou K; Terasmaa A; Quarta D; Solinas M; Justinova Z; Pezzola A; Reggio R; Müller CE; Fuxe K; Goldberg SR; Popoli P; Ferré S
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A2A-adenosine receptor reserve for coronary vasodilation.
    Shryock JC; Snowdy S; Baraldi PG; Cacciari B; Spalluto G; Monopoli A; Ongini E; Baker SP; Belardinelli L
    Circulation; 1998 Aug; 98(7):711-8. PubMed ID: 9715864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine A2A receptors and neuroprotection.
    Ongini E; Adami M; Ferri C; Bertorelli R
    Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.
    De Sarro G; De Sarro A; Di Paola ED; Bertorelli R
    Eur J Pharmacol; 1999 Apr; 371(2-3):137-45. PubMed ID: 10357250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum.
    Okada M; Mizuno K; Kaneko S
    Neurosci Lett; 1996 Jul; 212(1):53-6. PubMed ID: 8823761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine-dopamine interactions revealed in knockout mice.
    Salmi P; Chergui K; Fredholm BB
    J Mol Neurosci; 2005; 26(2-3):239-44. PubMed ID: 16012197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.
    Baldo BA; Koob GF; Markou A
    J Neurosci; 1999 Dec; 19(24):11017-26. PubMed ID: 10594082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
    Smith L; De Salvia M; Jenner P; Marsden CD
    Mov Disord; 1996 Mar; 11(2):125-35. PubMed ID: 8684381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.